Twist Bioscience Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Cash & Equivalents	183.05	226.32	286.47	378.69	465.83
Short-Term Investments	49.39	50.08	49.94	126.28	12.03
Cash & Short-Term Investments	232.43	276.4	336.41	504.97	477.86
Cash Growth	-15.91%	-17.84%	-33.38%	5.67%	64.78%
Accounts Receivable	57.02	34.9	44.06	40.29	26.21
Other Receivables	-	-	-	-	2.34
Receivables	57.02	34.9	44.06	40.29	28.55
Inventory	28.31	24.08	32.06	39.31	31.8
Prepaid Expenses	15.2	11.4	11.72	11.91	8.28
Total Current Assets	332.97	346.78	424.26	596.48	546.5
Property, Plant & Equipment	151.66	161.35	203.36	214.39	105.7
Long-Term Investments	54.34	1.53	-	-	-
Goodwill	82.2	85.81	85.81	85.81	22.43
Other Intangible Assets	13.43	14.48	54.48	59.74	18.26
Other Long-Term Assets	5.48	4.38	8.49	4.96	6.18
Total Assets	641.86	614.32	776.4	961.38	702.1
Accounts Payable	11.09	1.63	14.05	20.09	14.9
Accrued Expenses	54.34	48.75	36.57	37.19	28.76
Current Portion of Long-Term Debt	-	-	-	-	1.55
Current Portion of Leases	13.82	14.81	14.9	13.64	8.21
Current Income Taxes Payable	4.54	2.73	4.37	3.66	2.44
Current Unearned Revenue	6.88	2.13	3	3.48	1.09
Other Current Liabilities	0.72	0.96	0.43	12.6	6.1
Total Current Liabilities	91.41	71.01	73.32	90.66	63.05
Long-Term Debt	15	-	-	-	-
Long-Term Leases	61.75	70.22	79.17	81.27	53.16
Other Long-Term Liabilities	0.75	0.41	0.48	0.06	5.07
Total Liabilities	168.9	141.63	152.97	171.99	121.28
Additional Paid-In Capital	1,793	1,715	1,657	1,620	1,191
Retained Earnings	-1,320	-1,242	-1,033	-828.42	-610.55
Comprehensive Income & Other	-0.63	-0.52	-0.76	-1.84	0.55
Total Common Equity	472.96	472.69	623.43	789.39	580.82
Shareholders' Equity	472.96	472.69	623.43	789.39	580.82
Total Liabilities & Equity	641.86	614.32	776.4	961.38	702.1
Total Debt	90.57	85.03	94.07	94.91	62.92
Net Cash (Debt)	141.86	191.37	242.34	410.06	414.94
Net Cash Growth	-25.87%	-21.03%	-40.90%	-1.18%	63.35%
Net Cash Per Share	2.37	3.30	4.26	7.61	8.60
Filing Date Shares Outstanding	61.15	59.36	57.67	56.57	49.63
Total Common Shares Outstanding	60.63	58.88	57.56	56.52	49.5
Working Capital	241.56	275.77	350.93	505.82	483.44
Book Value Per Share	7.80	8.03	10.83	13.97	11.73
Tangible Book Value	377.34	372.4	483.14	643.84	540.13
Tangible Book Value Per Share	6.22	6.33	8.39	11.39	10.91
Machinery	107.88	105.93	111.18	67.43	53.61
Construction In Progress	20.12	4.69	8.53	87.72	16.97
Leasehold Improvements	58.28	57.45	57.27	14.37	5.07

Source: S&P Global Market Intelligence. Standard template. Financial Sources.